Abstract
We have tested two rapid assays of p53 function, namely the apoptotic assay and the FASAY as means of detecting germline p53 mutations in members of Li–Fraumeni and Li–Fraumeni-like families. Results of the functional assays have been compared with direct sequencing of all 11 exons of the p53 gene. The results show good agreement between the two functional assays and between them and sequencing. No false-positives or negatives were seen with either functional assay although the apoptotic assay gave one borderline result for an individual without a mutation. As an initial screen the apoptotic assay is not only rapid but inexpensive and very simple to perform. It would be expected to detect any germline defect that leads to loss of p53 function. The apoptotic assay could be ideal as a means of prescreening large numbers of samples and identifying those that require further investigation. The FASAY detects mutations in exons 4–10, is rapid and distinguishes between functionally important and silent mutations. © 2000 Cancer Research Campaign
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Birch JM, Hartley AL, Tricker KJ and Prosser J (1994) Prevalence and diversity of constitutional mutations in the p53 gene among 21 Li–Fraumeni families. Cancer Res 54: 1298–1304
Camplejohn RS, Perry P, Hodgson SV and Turner G (1995) A possible screening test for inherited p53-related defects based on the apoptotic response of peripheral blood lymphocytes to DNA damage. Br J Cancer 72: 654–662
Casey G, Lopez ME, Ramos JC and Plummer SJ (1996) DNA sequence analysis of exons 2 through 11 and immunohistochemical staining are required to detect all known p53 alterations in human malignancies. Oncogene 13: 1971–1981
Eeles RA (1995) Germline mutations in the TP53 gene. Cancer Surv 25: 101–124
Flaman JM, Frebourg T, Moreau V and Charbonnier F (1995) A simple p53 functional assay for screening cell lines, blood and tumours. Proc Natl Acad Sci USA 92: 3963–3967
Li FP and Fraumeni JF (1969) Soft-tissue sarcomas, breast cancer and other neoplasms. Ann Int Med 71: 747–752
Lomax ME, Barnes DM, Gilchrist R, Picksley SM, Varley JM and Camplejohn RS (1997) Two functional assays employed to detect an unusual mutation in the oligomerisation domain of p53 in a Li–Fraumeni like family. Oncogene 14: 1869–1874
Malkin D, Li FP, Strong LC and Fraumeni JF (1990) Germline p53 mutations in a familial syndrome of breast cancer, sarcomas and other neoplasms. Science 250: 1233–1238
Varley JM, Mcgown G, Thorncroft M, Santibanezkoref MF, Kelsey AM, Tricker KJ, Evans DGR and Birch JM (1997) Germ-line mutations of TP53 in Li–Fraumeni families: an extended study of 39 families. Cancer Res 57: 3245–3252
Varley JM, Chapman P, Mcgown G and Thorncroft M (1998) Genetic and functional studies of a germline TP53 splicing mutation in a Li–Fraumeni-like family. Oncogene 16: 3291–3298
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Camplejohn, R., Sodha, N., Gilchrist, R. et al. The value of rapid functional assays of germline p53 status in LFS and LFL families. Br J Cancer 82, 1145–1148 (2000). https://doi.org/10.1054/bjoc.1999.1054
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1054/bjoc.1999.1054
Keywords
This article is cited by
-
Heritability of DNA-damage-induced apoptosis and its relationship with age in lymphocytes from female twins
British Journal of Cancer (2006)
-
Apoptosis, ageing and cancer susceptibility
British Journal of Cancer (2003)
-
Investigations on a clinically and functionally unusual and novel germline p53 mutation
British Journal of Cancer (2002)
